Shire Targets Apotex Over Plan For Generic ADHD Drug
Shire LLC accused generic-drug maker Apotex Inc. on Thursday of violating its intellectual property by seeking to sell a copy of Shire's attention deficit hyperactivity disorder drug Intuniv before the patents...To view the full article, register now.
Already a subscriber? Click here to view full article